Manufacturer copay assistance · Rystiggo (J9333) · UCB
Eligible patients may… · Maximum benefit Eligible patients may receive RYSTIGGO at no cost for up to 12 months · Provides RYSTIGGO itself at no cost; the page does not say whether administration is covered
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
Rystiggo billing & access teams: these are the manufacturer's own published steps.
Published eligibility terms from the manufacturer. Exact eligibility is confirmed at enrollment.
Other requirements
Rystiggo (rozanolixizumab-noli) is billed under J9333 on the medical benefit when it's administered in a provider setting — that's the claim this patient assistance applies against.
Other assistance options for Rystiggo, in case this program doesn't fit — status shown as of each source's last verification.
Run a benefits estimate for Rystiggo — the program's cap applies against the patient share CareCost calculates.
Yes — The RYSTIGGO Patient Assistance Program from UCB. Eligible patients may receive RYSTIGGO at no cost for up to 12 months. Commercial insurance is typically required.
See program terms. Maximum benefit: Eligible patients may receive RYSTIGGO at no cost for up to 12 months. Provides RYSTIGGO itself at no cost; the page does not say whether administration is covered
Eligible patients may receive RYSTIGGO at no cost for up to 12 months.